Coats' disease with macular oedema responsive to aflibercept and argon laser.

DISCUSSION: Treatment with aflibercept and argon laser was effective in our patient with stage 2B Coats' disease and macular oedema unresponsive to ranibizumab. PMID: 28038924 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28038924?dopt=Abstract

Source: Archivos de la Sociedad Espanola de Oftalmologia - January 4, 2017 Category: Opthalmology Tags: Arch Soc Esp Oftalmol Source Type: research

More News: Lucentis | Opthalmology | Ranibizumab Injection